The Effect of Mild Weight Loss on Circulating Metabolite Profiles
Not Applicable
Completed
- Conditions
- Weight LossVisceral Fat
- Interventions
- Behavioral: Control groupBehavioral: LCD group
- Registration Number
- NCT03135132
- Lead Sponsor
- Yonsei University
- Brief Summary
To determine whether low calorie diet (LCD)-induced weight reduction caused changes in plasma metabolites and metabolic traits from baseline.
- Detailed Description
Over a 12-week clinical intervention period, a randomized, controlled study was carried out; overweight subjects consumed a LCD (approximately 300kcal/d deficit, n=47) or a weight-maintenance diet (control, n=50) were included for analyzing plasma samples and metabolites using an ultra-performance liquid chromatography and mass spectrometry (UPLC-LTQ/Orbitrap MS).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Able to give informed consent
- 20-65 years old
- Males and females
- Overweight (25.0 kg/m²≤ Body mass index <30 kg/m²)
- Nondiabetic (Fasting glucose <126 mg/dL)
Read More
Exclusion Criteria
- Unstable body weight (body weight change >1 kg within 3 months before screening)
- Consumption of medication that affects body weight or energy expenditure
- Pregnancy or breast-feeding
- Hypertension, type 2 diabetes, cardiovascular disease, cerebrovascular disease, or thyroid disease
- Liver disease, kidney disease, or gastrointestinal disease
- Acute or chronic infections
- Any acute or chronic disease requiring treatment
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control group Control group Usual dietary intake group LCD group LCD group Low calorie diet (LCD) group (300kcal/day intake reduction)
- Primary Outcome Measures
Name Time Method Visceral fat area at L4 (CT) At 12-week follow-up Change in visceral fat area at L4 from baseline At baseline and 12-week follow-up Putatively identified plasma metabolites (Normalized peak intensities) At 12-week follow-up Changes in putatively identified plasma metabolites (Normalized peak intensities) from baseline At baseline and 12-week follow-up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Yonsei University
🇰🇷Seoul, Korea, Republic of